Stenocare AS
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD oil products. The company was incorporated in 2017 and is based in Randers, Denmark.
Stenocare AS (STENO) - Total Liabilities
Latest total liabilities as of December 2025: Dkr3.09 Million DKK
Based on the latest financial reports, Stenocare AS (STENO) has total liabilities worth Dkr3.09 Million DKK as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Stenocare AS - Total Liabilities Trend (2018–2025)
This chart illustrates how Stenocare AS's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Stenocare AS Competitors by Total Liabilities
The table below lists competitors of Stenocare AS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
paragon GmbH & Co. KGaA
F:PGN
|
Germany | €106.61 Million |
|
Dynaciate Group Bhd
KLSE:5178
|
Malaysia | RM63.32 Million |
|
Semilux International Ltd. Ordinary Shares
NASDAQ:SELX
|
USA | $165.48 Million |
|
VIOL Co. Ltd
KQ:335890
|
Korea | ₩5.60 Billion |
|
Acrux Limited
PINK:ARUXF
|
USA | $6.20 Million |
|
Marvel Biosciences Corp.
PINK:MBCOF
|
USA | $4.33 Million |
|
Neurobo Pharmaceuticals Inc
NASDAQ:NRBO
|
USA | $9.19 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down Stenocare AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.52 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Stenocare AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Stenocare AS (2018–2025)
The table below shows the annual total liabilities of Stenocare AS from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Dkr3.09 Million | -86.66% |
| 2024-12-31 | Dkr23.17 Million | +88.35% |
| 2023-12-31 | Dkr12.30 Million | -20.45% |
| 2022-12-31 | Dkr15.46 Million | +318.65% |
| 2021-12-31 | Dkr3.69 Million | -2.03% |
| 2020-12-31 | Dkr3.77 Million | -79.21% |
| 2019-12-31 | Dkr18.13 Million | +1364.32% |
| 2018-12-31 | Dkr1.24 Million | -- |